Koninklijke Philips N.V.
Ambu A/S
MicroPort Scientific CorporationTeletherapy Services
North America · 2 shared keywords
North America Digital CBT Programs Market Industry Trends and Forecast to 2034: Segmented by (Condition, Model, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Overview
North America · 2024–2034 · estimates
Market Dashboard
Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Estimate 2024
$1.29 Bn
Estimated value
Estimate 2025
$1.51 Bn
45.1% of the global market
Projected 2034
$6.34 Bn 320.4%
Adds $4.83 Bn over 9 forecast years
CAGR 2025–2034
17.3%
Faster than 64% of 100 Digital Health markets here
Key players
5
Companies profiled
- North America is 45.12% of the global market.
- Among regions, the largest is North America (this report) at $1.51 Bn.
- Fastest growing: Africa at 19.9% a year.
- North America ranks 1st of 6 by size among regions.
Market size projection
North AmericaSource: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
Value added each year
$4.83 Bn total, 2026–2034
Year-by-year market size, 2024–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $1.29 Bn | — | — |
| 2025 (base) | $1.51 Bn | +$222.4 Mn | — |
| 2026 (forecast) | $1.77 Bn | +$260.8 Mn | +17.3% |
| 2027 (forecast) | $2.07 Bn | +$306.0 Mn | +37.6% |
| 2028 (forecast) | $2.43 Bn | +$358.9 Mn | +61.4% |
| 2029 (forecast) | $2.85 Bn | +$421.0 Mn | +89.3% |
| 2030 (forecast) | $3.35 Bn | +$493.8 Mn | +122.1% |
| 2031 (forecast) | $3.93 Bn | +$579.2 Mn | +160.5% |
| 2032 (forecast) | $4.61 Bn | +$679.5 Mn | +205.6% |
| 2033 (forecast) | $5.40 Bn | +$797.0 Mn | +258.4% |
| 2034 (forecast) | $6.34 Bn | +$934.9 Mn | +320.4% |
Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
Same market worldwide
By geography
- Global $3.34 Bn
- North America (this report) $1.51 Bn
-
US
$1.17 Bn
- APAC $798.9 Mn
- Europe $578.9 Mn
-
Canada
$300.8 Mn
-
China
$279.4 Mn
-
Japan
$210.3 Mn
- Latin America $171.8 Mn
- Middle East $148.5 Mn
-
Germany
$106.4 Mn
-
UK
$92.3 Mn
-
France
$83.5 Mn
-
Brazil
$78.9 Mn
-
Ecuador
$77.0 Mn
-
Italy
$70.9 Mn
-
India
$71.5 Mn
-
Spain
$66.4 Mn
-
Saudi Arabia
$60.0 Mn
-
Mexico
$53.4 Mn
- Africa $52.0 Mn
-
Australia
$39.5 Mn
-
Russia
$31.3 Mn
-
New Zealand
$29.1 Mn
-
South Africa
$21.8 Mn
-
UAE
$19.5 Mn
-
Egypt
$8.3 Mn
-
Philippines
$7.5 Mn
-
Malaysia
$5.7 Mn
-
Hong Kong
$5.1 Mn
-
Singapore
$4.5 Mn
-
Thailand
$3.7 Mn
-
Kenya
$2.3 Mn
The North America Digital CBT Programs Market Analysis Executive Summary
Digital CBT programs deliver cognitive behavioural therapy through apps and online courses for insomnia, anxiety and depression.
Key segments of the digital CBT Programs market include condition (Insomnia, Anxiety and Depression) and model (Prescription Digital Therapeutics and Wellness Apps).
North America Digital CBT Programs Market Dynamics
Market Growth Drivers
More people seeking help for mental health, less stigma, better screening and new treatments with faster effects are driving the digital CBT Programs market. Governments and employers are investing more in mental health care.
Opportunity
Digital tools, new drug classes and care built into primary care and workplaces give the digital CBT Programs market strong room to grow worldwide.
Market Restraints
Shortages of mental health professionals, limited insurance coverage, side effects and the need for long-term treatment hold back the digital CBT Programs market.
Competitive Landscape for Digital CBT Programs Market in North America
The digital CBT Programs market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Key Players
Healthcare Policies and Regulatory Landscape for Digital CBT Programs Market in North America
Policy changes and Reimbursement scenario
Rules on software as a medical device, data privacy (such as HIPAA and GDPR) and telehealth reimbursement shape the digital CBT Programs market. Government digital health programs in North America are speeding up adoption.
Beyond the market numbers
Research, trials and patients
What doctors and scientists are doing in Digital CBT Programs right now, from free public sources.
Latest research 156 papers since 2021 (worldwide)
- Non Pharmacological Pain Management in Sickle Cell Disease, a Narrative Review. Journal of pain research, 2026
- Lived Experiences of Endometriosis-Related Pain and Perceptions of a Blended Digital CBT Intervention: A Mixed-Methods Study. Pain research & management, 2026
- Phase-sensitive integration of motivational interviewing and cognitive behavioral therapy for anxiety disorders: a scoping review. BMC psychiatry, 2026
- Digital cognitive behavioral therapy versus Education for chronic pain in adults with sickle cell disease: 12-month randomized trial results. Annals of behavioral medicine : a publication of the Society of Behavioral Medicine, 2026
- Pharmacological and non-pharmacological interventions of insomnia in geriatrics: A systematic review. The Medical journal of Malaysia, 2026
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
Public data, with sources
Digital CBT Programs in context
Questions, answered with public data
- How much research is published on Digital CBT Programs?
- PubMed lists 156 papers added since January 2021 that match this market, worldwide.[1]
[1] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Free data on this topic
From our blog
Adaptogens: Ancient Herbs, Modern Market170 WHO Member States report the use of traditional medicine. Adaptogens like ashwagandha, rhodiola and…
Stress and Mood Supplements: Ashwagandha and BeyondDepression and anxiety cost the world about US$1 trillion a year. Ashwagandha has some evidence for stress…
Sleep Aids: Why So Many People Can't SleepAbout 3 in 10 US adults sleep less than 7 hours. Melatonin helps with jet lag and shift work, but its effect…